Blood Stem Cell Mutations and Their Potential Role in Reducing Alzheimer's Disease Risk
Research reveals that mutations in blood stem cells, particularly in the TET2 gene, may significantly reduce the risk of late-onset Alzheimer's disease by enhancing brain immune responses.
A groundbreaking study published in Cell Stem Cell has uncovered intriguing links between mutations in blood stem cells and a decreased risk of developing late-onset Alzheimer's disease. Researchers from Baylor College of Medicine found that specific genetic mutations, particularly in the TET2 gene, may offer protective effects against the progression of this neurodegenerative disorder.
The investigation involved analyzing human data from the UK Biobank and conducting experiments on a mouse model. The team discovered that individuals with blood stem cells carrying mutations in TET2 had a 47% lower chance of developing Alzheimer's. Meanwhile, similar mutations in the DNMT3A gene did not confer such protective benefits.
In mouse models, transplantation of TET2-mutant bone marrow cells resulted in reduced cognitive decline and fewer beta-amyloid plaques, hallmark features of Alzheimer's disease. These results suggest that TET2-mutant immune cells, which can migrate into the brain, might aid in clearing amyloid deposits more effectively.
Lead researcher Dr. Katherine King explained that immune cells derived from TET2-mutant clones showed an increased ability to target brain damage related to Alzheimer's. This discovery challenges the traditional view that clonal hematopoiesis— the expansion of mutated blood cells— always promotes disease progression. Instead, certain mutations like those in TET2 may have protective roles.
The research emphasizes the importance of a mutation-specific perspective when evaluating clonal hematopoiesis and its health implications. Understanding how these mutations influence inflammation and immune response could lead to new strategies for preventing or treating Alzheimer's and other neurodegenerative diseases.
This study not only advances our knowledge of the complex relationship between blood cell genetics and brain health but also opens up new prospects for therapeutic interventions targeting immune cell function in Alzheimer's disease.
For more details, see the original research in Cell Stem Cell.
Source: https://medicalxpress.com/news/2025-07-blood-stem-cell-mutations-linked.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Advanced Risk Calculator Enhances 10-Year Prediction of Heart Disease and Detects Calcium Deposits in Arteries
A new study shows that the PREVENT risk calculator, combined with calcium scoring, accurately predicts 10-year cardiovascular risk and detects arterial calcium buildup, aiding in early intervention and prevention strategies.
Innovative Machine Learning Enhances Long-Read Cancer Genome Sequencing for Clinical Application
A groundbreaking machine learning algorithm called SAVANA enhances long-read sequencing analysis for cancer genomes, improving detection of structural variants and supporting personalized treatment. Developed by EMBL-EBI and partners, this tool promises to revolutionize clinical genomics and cancer diagnostics.
Simple and Cost-Effective Lp(a) Blood Test Could Revolutionize Cardiovascular Disease Prevention
A simple, cost-effective blood test for Lp(a) could transform cardiovascular disease prevention worldwide, enabling early detection and reducing healthcare costs. Discover how this testing can save lives.
Global Call for Equal Valuation of Patients, Caregivers, and Relatives in Healthcare
A new collection by The BMJ highlights the urgent need to value and integrate the lived experiences of patients, caregivers, and families in health decision-making worldwide. Experts call for systemic change to make participatory healthcare a routine practice, promoting equity and inclusivity in health systems.